These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 29508861)

  • 1. Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination.
    Kratochvil S; McKay PF; Chung AW; Kent SJ; Gilmour J; Shattock RJ
    Front Immunol; 2018; 9():342. PubMed ID: 29508861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination.
    Kratochvil S; McKay PF; Chung AW; Kent SJ; Gilmour J; Shattock RJ
    Front Immunol; 2017; 8():1883. PubMed ID: 29326728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis.
    Lossius A; Tomescu-Baciu A; Holmøy T; Vedeler CA; Røsjø E; Lorentzen ÅR; Casetta I; Vartdal F
    Ann Clin Transl Neurol; 2017 Oct; 4(10):756-761. PubMed ID: 29046884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G1m1 predominance of intrathecal virus-specific antibodies in multiple sclerosis.
    Tomescu-Baciu A; Vartdal F; Holmøy T; Vedeler CA; Lossius A
    Ann Clin Transl Neurol; 2018 Oct; 5(10):1303-1309. PubMed ID: 30349866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding.
    Ternant D; Arnoult C; Pugnière M; Dhommée C; Drocourt D; Perouzel E; Passot C; Baroukh N; Mulleman D; Tiraby G; Watier H; Paintaud G; Gouilleux-Gruart V
    J Immunol; 2016 Jan; 196(2):607-13. PubMed ID: 26685205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the ability of the human IgG1 allotypes G1m3 and G1m1,17 to stimulate T-cell responses from allotype matched and mismatched donors.
    Webster CI; Bryson CJ; Cloake EA; Jones TD; Austin MJ; Karle AC; Spindeldreher S; Lowe DC; Baker MP
    MAbs; 2016; 8(2):253-63. PubMed ID: 26821574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope characterization of pre-existing and developing antibodies to an aglycosylated monoclonal antibody therapeutic of G1m17,1 allotype.
    Tatarewicz SM; Juan G; Swanson SJ; Moxness MS
    J Immunol Methods; 2012 Aug; 382(1-2):93-100. PubMed ID: 22609464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Recent Advances in Lentiviral Vaccines for HIV-1 Infection.
    Norton TD; Miller EA
    Front Immunol; 2016; 7():354. PubMed ID: 27630642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum.
    Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
    J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines.
    Wan Y; Wu L; Liu L; Xu J; Liu Y; Liu Y; Shao Y
    Vaccine; 2007 Jun; 25(26):4949-59. PubMed ID: 17350736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.
    Ambrosino DM; Schiffman G; Gotschlich EC; Schur PH; Rosenberg GA; DeLange GG; van Loghem E; Siber GR
    J Clin Invest; 1985 Jun; 75(6):1935-42. PubMed ID: 3924957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
    Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins.
    Ha JH; Kim JE; Kim YS
    Front Immunol; 2017; 8():1582. PubMed ID: 29151837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Specific Antibody Deficiency: Controversies in Diagnosis and Management.
    Perez E; Bonilla FA; Orange JS; Ballow M
    Front Immunol; 2018; 9():450. PubMed ID: 29576764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
    Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
    Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
    J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No influence of conversions affecting allotype expression on the IgG subclass restriction of specific antibodies.
    Hammarström L; Dugoujon JM; de Lange GG; Ghanem N; Lefranc G; Smith CI
    Exp Clin Immunogenet; 1989; 6(1):60-7. PubMed ID: 2629888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression.
    López-Abente J; Correa-Rocha R; Pion M
    Front Immunol; 2018; 9():792. PubMed ID: 29713329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype.
    Granoff DM; Pandey JP; Boies E; Squires J; Munson RS; Suarez B
    J Clin Invest; 1984 Nov; 74(5):1708-14. PubMed ID: 6334101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.